140 related articles for article (PubMed ID: 32758941)
1. GPRC5A reduction contributes to pollutant benzo[a]pyrene injury via aggravating murine fibrosis, leading to poor prognosis of IIP patients.
Huang Z; Wang S; Liu Y; Fan L; Zeng Y; Han H; Zhang H; Yu X; Zhang Y; Huang D; Wu Y; Jiang W; Zhu P; Zhu X; Yi X
Sci Total Environ; 2020 Oct; 739():139923. PubMed ID: 32758941
[TBL] [Abstract][Full Text] [Related]
2. Epithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposure.
Wang X; Xu D; Liao Y; Zhong S; Song H; Sun B; Zhou BP; Deng J; Han B
Oncotarget; 2015 Nov; 6(37):39578-93. PubMed ID: 26447616
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
[TBL] [Abstract][Full Text] [Related]
5. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation.
Meneghin A; Choi ES; Evanoff HL; Kunkel SL; Martinez FJ; Flaherty KR; Toews GB; Hogaboam CM
Histochem Cell Biol; 2008 Nov; 130(5):979-92. PubMed ID: 18633634
[TBL] [Abstract][Full Text] [Related]
6. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K; Hamada N; Tokunaga S; Ichiki K; Takata S; Ishii H; Kitasato Y; Okamoto M; Kawakami S; Yatera K; Kawasaki M; Fujita M; Yoshida M; Maeyama T; Harada T; Wataya H; Torii R; Komori M; Mizuta Y; Tobino K; Harada E; Yabuuchi H; Nakanishi Y; Okamoto I
BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37963676
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
Krauss E; Gehrken G; Drakopanagiotakis F; Tello S; Dartsch RC; Maurer O; Windhorst A; von der Beck D; Griese M; Seeger W; Guenther A
BMC Pulm Med; 2019 Jul; 19(1):130. PubMed ID: 31319833
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
Huang LS; Fu P; Patel P; Harijith A; Sun T; Zhao Y; Garcia JG; Chun J; Natarajan V
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):912-22. PubMed ID: 23808384
[TBL] [Abstract][Full Text] [Related]
9. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
10. Liproxstatin-1 alleviates bleomycin-induced alveolar epithelial cells injury and mice pulmonary fibrosis via attenuating inflammation, reshaping redox equilibrium, and suppressing ROS/p53/α-SMA pathway.
Tao N; Li K; Liu J; Fan G; Sun T
Biochem Biophys Res Commun; 2021 Apr; 551():133-139. PubMed ID: 33735625
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
12. [The expressions and meanings of BMP-7 and TGF-β in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia].
Gu P; Luo B; Yi X; Zhu H; Li S; Yu X; Han F; Zhang S; Zhu X; Rui W; Qiu W; Fan D
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Sep; 37(9):664-70. PubMed ID: 25533688
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis.
Tzouvelekis A; Aidinis V; Harokopos V; Karameris A; Zacharis G; Mikroulis D; Konstantinou F; Steiropoulos P; Sotiriou I; Froudarakis M; Pneumatikos I; Tringidou R; Bouros D
Respir Res; 2009 Feb; 10(1):14. PubMed ID: 19250543
[TBL] [Abstract][Full Text] [Related]
14. Gprc5a-deficiency confers susceptibility to endotoxin-induced acute lung injury via NF-κB pathway.
Liao Y; Song H; Xu D; Jiao H; Yao F; Liu J; Wu Y; Zhong S; Yin H; Liu S; Wang X; Guo W; Sun B; Han B; Chin YE; Deng J
Cell Cycle; 2015; 14(9):1403-12. PubMed ID: 25714996
[TBL] [Abstract][Full Text] [Related]
15. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis.
Tzilas V; Bouros E; Barbayianni I; Karampitsakos T; Kourtidou S; Ntassiou M; Ninou I; Aidinis V; Bouros D; Tzouvelekis A
Pulm Pharmacol Ther; 2019 Apr; 55():17-24. PubMed ID: 30659895
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
Li HH; Liu CC; Hsu TW; Lin JH; Hsu JW; Li AF; Yeh YC; Hung SC; Hsu HS
Part Fibre Toxicol; 2021 Mar; 18(1):11. PubMed ID: 33706759
[TBL] [Abstract][Full Text] [Related]
18. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of patients with chronic idiopathic interstitial pneumonia undergoing repeated respiratory-related hospitalizations: A retrospective cohort study.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
PLoS One; 2020; 15(4):e0232212. PubMed ID: 32330195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
